Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prehypertension | 5 | 2012 | 61 | 1.890 |
Why?
|
Prediabetic State | 4 | 2012 | 493 | 1.100 |
Why?
|
Blood Vessel Prosthesis | 8 | 2020 | 933 | 1.000 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2019 | 1181 | 0.900 |
Why?
|
Blood Vessel Prosthesis Implantation | 8 | 2020 | 1384 | 0.840 |
Why?
|
Nitrobenzenes | 2 | 2012 | 65 | 0.830 |
Why?
|
Endovascular Procedures | 10 | 2020 | 1973 | 0.830 |
Why?
|
Methemoglobinemia | 2 | 2012 | 44 | 0.810 |
Why?
|
Nitrogen | 4 | 2017 | 343 | 0.740 |
Why?
|
Gene Expression Regulation, Plant | 5 | 2014 | 201 | 0.700 |
Why?
|
Hospital Planning | 1 | 2018 | 20 | 0.670 |
Why?
|
Flowers | 3 | 2014 | 28 | 0.640 |
Why?
|
Orchidaceae | 2 | 2014 | 4 | 0.630 |
Why?
|
Tracheotomy | 1 | 2019 | 166 | 0.630 |
Why?
|
Genes, Plant | 3 | 2014 | 124 | 0.630 |
Why?
|
Stents | 9 | 2020 | 3276 | 0.630 |
Why?
|
Eleusine | 2 | 2014 | 2 | 0.590 |
Why?
|
Pollination | 2 | 2013 | 4 | 0.560 |
Why?
|
Nitrates | 2 | 2019 | 265 | 0.550 |
Why?
|
Blood Pressure | 9 | 2015 | 8541 | 0.550 |
Why?
|
Models, Educational | 1 | 2019 | 377 | 0.550 |
Why?
|
Eugenol | 1 | 2014 | 10 | 0.510 |
Why?
|
Disaster Planning | 2 | 2018 | 549 | 0.500 |
Why?
|
Cyclosporine | 1 | 2017 | 784 | 0.500 |
Why?
|
Perception | 1 | 2021 | 1188 | 0.490 |
Why?
|
Operating Rooms | 2 | 2018 | 813 | 0.480 |
Why?
|
Fatigue | 1 | 2021 | 1526 | 0.470 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 167 | 0.450 |
Why?
|
Silene | 1 | 2012 | 1 | 0.450 |
Why?
|
Anisoles | 1 | 2012 | 6 | 0.440 |
Why?
|
Eucommiaceae | 1 | 2011 | 3 | 0.420 |
Why?
|
Plant Bark | 1 | 2011 | 9 | 0.420 |
Why?
|
Prosthesis-Related Infections | 1 | 2018 | 538 | 0.420 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2414 | 0.410 |
Why?
|
Mexican Americans | 1 | 2012 | 166 | 0.400 |
Why?
|
Volatile Organic Compounds | 1 | 2012 | 81 | 0.400 |
Why?
|
Phentermine | 1 | 2011 | 33 | 0.400 |
Why?
|
Sclerostomy | 1 | 2011 | 15 | 0.390 |
Why?
|
Anti-Obesity Agents | 2 | 2011 | 215 | 0.380 |
Why?
|
Femur Neck | 1 | 2012 | 309 | 0.370 |
Why?
|
Alkylating Agents | 1 | 2011 | 139 | 0.370 |
Why?
|
Plant Proteins | 4 | 2013 | 364 | 0.370 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2018 | 5425 | 0.370 |
Why?
|
Mitomycin | 1 | 2011 | 259 | 0.360 |
Why?
|
Aortography | 4 | 2019 | 431 | 0.360 |
Why?
|
Nitric Oxide | 3 | 2016 | 2128 | 0.350 |
Why?
|
Vitamin D | 3 | 2012 | 3211 | 0.350 |
Why?
|
Methyltransferases | 1 | 2012 | 367 | 0.350 |
Why?
|
Phytotherapy | 1 | 2011 | 298 | 0.350 |
Why?
|
Sclera | 1 | 2011 | 200 | 0.350 |
Why?
|
Iliac Vein | 2 | 2020 | 72 | 0.350 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2011 | 534 | 0.340 |
Why?
|
Circadian Rhythm | 2 | 2011 | 2623 | 0.340 |
Why?
|
Thiazolidinediones | 2 | 2010 | 476 | 0.340 |
Why?
|
Glutathione | 1 | 2012 | 586 | 0.340 |
Why?
|
Lymphoma | 1 | 2018 | 1873 | 0.340 |
Why?
|
Hypertension | 5 | 2012 | 8455 | 0.340 |
Why?
|
Energy Intake | 3 | 2016 | 2147 | 0.320 |
Why?
|
Plant Extracts | 1 | 2011 | 469 | 0.320 |
Why?
|
Body Composition | 3 | 2016 | 2400 | 0.310 |
Why?
|
Bone Diseases, Metabolic | 1 | 2012 | 417 | 0.310 |
Why?
|
Body Weight | 5 | 2015 | 4664 | 0.310 |
Why?
|
Metformin | 2 | 2018 | 829 | 0.310 |
Why?
|
Terrorism | 3 | 2015 | 211 | 0.300 |
Why?
|
Lomustine | 2 | 2018 | 59 | 0.300 |
Why?
|
Antihypertensive Agents | 3 | 2012 | 2043 | 0.300 |
Why?
|
Body Mass Index | 9 | 2017 | 12695 | 0.290 |
Why?
|
Trauma Centers | 4 | 2018 | 889 | 0.290 |
Why?
|
Weight Loss | 6 | 2013 | 2604 | 0.290 |
Why?
|
Cardiovascular Diseases | 6 | 2013 | 15108 | 0.280 |
Why?
|
Blood Glucose | 6 | 2015 | 6249 | 0.280 |
Why?
|
Weight Gain | 2 | 2013 | 2282 | 0.260 |
Why?
|
Etoposide | 2 | 2018 | 637 | 0.260 |
Why?
|
Waist Circumference | 4 | 2014 | 917 | 0.260 |
Why?
|
Hip Joint | 1 | 2012 | 1002 | 0.260 |
Why?
|
Cytarabine | 2 | 2018 | 684 | 0.260 |
Why?
|
Endothelium, Vascular | 3 | 2015 | 4455 | 0.260 |
Why?
|
Prosthesis Design | 7 | 2020 | 2110 | 0.250 |
Why?
|
Plant Leaves | 3 | 2016 | 143 | 0.250 |
Why?
|
Hypoglycemic Agents | 3 | 2018 | 2866 | 0.250 |
Why?
|
Bombs | 2 | 2015 | 72 | 0.250 |
Why?
|
Middle Aged | 47 | 2021 | 213127 | 0.250 |
Why?
|
Prognosis | 5 | 2023 | 29010 | 0.240 |
Why?
|
Glaucoma, Open-Angle | 1 | 2011 | 711 | 0.240 |
Why?
|
Adiposity | 5 | 2015 | 1806 | 0.230 |
Why?
|
Adipose Tissue | 3 | 2013 | 3278 | 0.230 |
Why?
|
Male | 62 | 2020 | 349538 | 0.230 |
Why?
|
Intuition | 1 | 2023 | 20 | 0.230 |
Why?
|
Female | 60 | 2021 | 379592 | 0.220 |
Why?
|
Heart Rate | 2 | 2011 | 4091 | 0.220 |
Why?
|
Wounds, Nonpenetrating | 3 | 2014 | 794 | 0.220 |
Why?
|
Lumbar Vertebrae | 1 | 2012 | 1844 | 0.220 |
Why?
|
Osteoporosis | 1 | 2012 | 1581 | 0.210 |
Why?
|
Obesity | 6 | 2013 | 12705 | 0.210 |
Why?
|
Endoleak | 2 | 2020 | 101 | 0.210 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3497 | 0.200 |
Why?
|
Subcutaneous Fat, Abdominal | 3 | 2014 | 92 | 0.200 |
Why?
|
Inflammation | 6 | 2016 | 10578 | 0.200 |
Why?
|
Humans | 80 | 2023 | 742088 | 0.200 |
Why?
|
Adult | 35 | 2020 | 213712 | 0.200 |
Why?
|
Methylene Blue | 2 | 2012 | 155 | 0.200 |
Why?
|
Molecular Sequence Annotation | 2 | 2014 | 527 | 0.190 |
Why?
|
Cyclophosphamide | 2 | 2018 | 2236 | 0.190 |
Why?
|
Antidotes | 2 | 2012 | 138 | 0.190 |
Why?
|
C-Reactive Protein | 5 | 2016 | 3766 | 0.190 |
Why?
|
Adiponectin | 3 | 2011 | 1099 | 0.190 |
Why?
|
Liver | 3 | 2012 | 7470 | 0.190 |
Why?
|
Factitious Disorders | 1 | 2020 | 41 | 0.180 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7153 | 0.180 |
Why?
|
Iliac Aneurysm | 1 | 2020 | 38 | 0.180 |
Why?
|
Treatment Outcome | 24 | 2020 | 62966 | 0.180 |
Why?
|
Heart Diseases | 2 | 2013 | 2789 | 0.180 |
Why?
|
Risk Factors | 22 | 2023 | 72145 | 0.180 |
Why?
|
Nutrition Surveys | 3 | 2012 | 1656 | 0.180 |
Why?
|
Skin Diseases, Vascular | 1 | 2020 | 39 | 0.180 |
Why?
|
Transplantation Conditioning | 2 | 2018 | 1597 | 0.180 |
Why?
|
DNA, Complementary | 2 | 2014 | 2049 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9185 | 0.180 |
Why?
|
Quality of Life | 1 | 2021 | 12730 | 0.180 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2018 | 1379 | 0.170 |
Why?
|
Bupropion | 2 | 2013 | 303 | 0.170 |
Why?
|
Hodgkin Disease | 2 | 2018 | 1413 | 0.170 |
Why?
|
Bone Density | 1 | 2012 | 3469 | 0.170 |
Why?
|
Naltrexone | 2 | 2013 | 307 | 0.170 |
Why?
|
Young Adult | 15 | 2020 | 56350 | 0.170 |
Why?
|
Aorta, Abdominal | 2 | 2019 | 645 | 0.170 |
Why?
|
Celiac Artery | 1 | 2018 | 68 | 0.170 |
Why?
|
Fatal Outcome | 3 | 2012 | 1849 | 0.160 |
Why?
|
Psychophysiologic Disorders | 1 | 2020 | 228 | 0.160 |
Why?
|
Plant Roots | 2 | 2016 | 109 | 0.160 |
Why?
|
Iliac Artery | 1 | 2020 | 364 | 0.160 |
Why?
|
Embolic Protection Devices | 1 | 2018 | 42 | 0.160 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 9410 | 0.160 |
Why?
|
Ascorbic Acid | 2 | 2012 | 647 | 0.160 |
Why?
|
India | 3 | 2020 | 2187 | 0.160 |
Why?
|
Glomerular Filtration Rate | 2 | 2018 | 2167 | 0.160 |
Why?
|
Cytokines | 3 | 2018 | 7317 | 0.150 |
Why?
|
Gases | 2 | 2016 | 197 | 0.150 |
Why?
|
Nitrogen Compounds | 1 | 2017 | 6 | 0.150 |
Why?
|
Time Factors | 15 | 2020 | 40054 | 0.150 |
Why?
|
Aged | 28 | 2020 | 162944 | 0.150 |
Why?
|
Multiple Organ Failure | 1 | 2020 | 389 | 0.150 |
Why?
|
Fertilizers | 1 | 2017 | 24 | 0.150 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 24913 | 0.150 |
Why?
|
Arabidopsis Proteins | 1 | 2019 | 262 | 0.150 |
Why?
|
Klippel-Trenaunay-Weber Syndrome | 1 | 2017 | 68 | 0.150 |
Why?
|
Surgical Wound Infection | 2 | 2017 | 1538 | 0.140 |
Why?
|
Kidney Transplantation | 1 | 2012 | 4246 | 0.140 |
Why?
|
Foreign-Body Migration | 1 | 2019 | 221 | 0.140 |
Why?
|
Arteriovenous Fistula | 1 | 2020 | 315 | 0.140 |
Why?
|
Peripheral Arterial Disease | 2 | 2018 | 1184 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2013 | 11695 | 0.140 |
Why?
|
Renal Artery | 1 | 2018 | 398 | 0.140 |
Why?
|
Dengue | 1 | 2020 | 256 | 0.140 |
Why?
|
Insulin Resistance | 5 | 2015 | 3861 | 0.140 |
Why?
|
Personnel, Hospital | 1 | 2018 | 283 | 0.140 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1889 | 0.140 |
Why?
|
Transplantation, Autologous | 2 | 2018 | 2123 | 0.140 |
Why?
|
Triglycerides | 3 | 2015 | 2450 | 0.140 |
Why?
|
Osteopontin | 1 | 2018 | 296 | 0.140 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8621 | 0.140 |
Why?
|
Vidarabine | 1 | 2017 | 345 | 0.140 |
Why?
|
Plant Diseases | 1 | 2017 | 150 | 0.140 |
Why?
|
Adolescent | 15 | 2018 | 85649 | 0.140 |
Why?
|
Diet, Reducing | 2 | 2010 | 461 | 0.140 |
Why?
|
Carmustine | 1 | 2016 | 137 | 0.140 |
Why?
|
Vena Cava Filters | 1 | 2019 | 252 | 0.140 |
Why?
|
Competency-Based Education | 1 | 2017 | 211 | 0.130 |
Why?
|
Plants | 1 | 2017 | 314 | 0.130 |
Why?
|
Arabidopsis | 1 | 2019 | 459 | 0.130 |
Why?
|
Mycophenolic Acid | 1 | 2017 | 343 | 0.130 |
Why?
|
Aortic Aneurysm | 1 | 2020 | 643 | 0.130 |
Why?
|
Phylogeny | 2 | 2013 | 2797 | 0.130 |
Why?
|
Chlorthalidone | 2 | 2012 | 19 | 0.130 |
Why?
|
Aneurysm, Ruptured | 1 | 2020 | 452 | 0.130 |
Why?
|
Curriculum | 2 | 2019 | 3589 | 0.130 |
Why?
|
Lisinopril | 2 | 2012 | 54 | 0.130 |
Why?
|
Evolution, Molecular | 2 | 2014 | 1937 | 0.120 |
Why?
|
Angioplasty, Balloon | 1 | 2019 | 653 | 0.120 |
Why?
|
Amlodipine | 2 | 2012 | 83 | 0.120 |
Why?
|
Electrocoagulation | 1 | 2015 | 158 | 0.120 |
Why?
|
Genotype | 3 | 2014 | 12946 | 0.120 |
Why?
|
Enzymes | 1 | 2016 | 266 | 0.120 |
Why?
|
Expressed Sequence Tags | 1 | 2014 | 255 | 0.120 |
Why?
|
Melphalan | 1 | 2016 | 431 | 0.120 |
Why?
|
Obesity, Morbid | 4 | 2014 | 1204 | 0.120 |
Why?
|
Prevalence | 4 | 2012 | 15194 | 0.120 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2015 | 236 | 0.120 |
Why?
|
Disaster Medicine | 1 | 2014 | 73 | 0.120 |
Why?
|
Thrombectomy | 1 | 2019 | 679 | 0.120 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20774 | 0.120 |
Why?
|
Caloric Restriction | 1 | 2016 | 302 | 0.120 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 361 | 0.120 |
Why?
|
Glutamate Synthase | 1 | 2013 | 3 | 0.120 |
Why?
|
Nitrate Reductase | 1 | 2013 | 9 | 0.120 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2018 | 686 | 0.120 |
Why?
|
Carotid Artery Diseases | 1 | 2020 | 882 | 0.110 |
Why?
|
Fires | 1 | 2015 | 173 | 0.110 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1203 | 0.110 |
Why?
|
Retrospective Studies | 19 | 2023 | 77098 | 0.110 |
Why?
|
Urinary Fistula | 1 | 2013 | 41 | 0.110 |
Why?
|
Logistic Models | 5 | 2018 | 13403 | 0.110 |
Why?
|
Guaiacol | 1 | 2012 | 5 | 0.110 |
Why?
|
Aged, 80 and over | 11 | 2020 | 57683 | 0.110 |
Why?
|
Ureteral Diseases | 1 | 2013 | 61 | 0.110 |
Why?
|
Species Specificity | 2 | 2014 | 2479 | 0.110 |
Why?
|
Wounds and Injuries | 2 | 2018 | 2400 | 0.110 |
Why?
|
Capillary Leak Syndrome | 1 | 2012 | 31 | 0.110 |
Why?
|
Anticoagulants | 2 | 2019 | 4595 | 0.110 |
Why?
|
Mass Casualty Incidents | 1 | 2015 | 181 | 0.110 |
Why?
|
Remission Induction | 1 | 2018 | 2384 | 0.110 |
Why?
|
Moths | 1 | 2012 | 85 | 0.110 |
Why?
|
Diaphragm | 1 | 2014 | 347 | 0.110 |
Why?
|
Biliary Fistula | 1 | 2012 | 36 | 0.110 |
Why?
|
Absorptiometry, Photon | 3 | 2014 | 1726 | 0.110 |
Why?
|
Neoplasms | 2 | 2012 | 21596 | 0.110 |
Why?
|
Body Fat Distribution | 1 | 2013 | 244 | 0.110 |
Why?
|
Rats, Inbred Dahl | 1 | 2011 | 35 | 0.100 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2012 | 74 | 0.100 |
Why?
|
Fever | 1 | 2020 | 1612 | 0.100 |
Why?
|
Appendectomy | 1 | 2015 | 400 | 0.100 |
Why?
|
Citrate (si)-Synthase | 1 | 2011 | 43 | 0.100 |
Why?
|
Recurrence | 3 | 2020 | 8333 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1171 | 0.100 |
Why?
|
Databases, Factual | 7 | 2020 | 7716 | 0.100 |
Why?
|
Leadership | 2 | 2018 | 1357 | 0.100 |
Why?
|
Gene Library | 1 | 2014 | 1076 | 0.100 |
Why?
|
Blast Injuries | 1 | 2015 | 302 | 0.100 |
Why?
|
Thoracic Injuries | 1 | 2014 | 272 | 0.100 |
Why?
|
Transcription Factors | 3 | 2019 | 12164 | 0.100 |
Why?
|
Hernia, Ventral | 1 | 2013 | 155 | 0.100 |
Why?
|
Vascular Surgical Procedures | 2 | 2017 | 1473 | 0.100 |
Why?
|
Signal Transduction | 3 | 2018 | 23387 | 0.100 |
Why?
|
Patient Transfer | 1 | 2018 | 760 | 0.100 |
Why?
|
Ascites | 1 | 2013 | 344 | 0.100 |
Why?
|
Self Concept | 1 | 2017 | 1025 | 0.100 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2018 | 1504 | 0.100 |
Why?
|
Sexual Maturation | 1 | 2013 | 265 | 0.100 |
Why?
|
Ontario | 1 | 2012 | 381 | 0.100 |
Why?
|
Pleural Diseases | 1 | 2012 | 139 | 0.100 |
Why?
|
Crime | 1 | 2012 | 215 | 0.100 |
Why?
|
Carotid Stenosis | 1 | 2018 | 854 | 0.100 |
Why?
|
Sex Factors | 3 | 2020 | 10392 | 0.100 |
Why?
|
Abdominal Injuries | 1 | 2014 | 352 | 0.100 |
Why?
|
Methotrexate | 1 | 2017 | 1720 | 0.090 |
Why?
|
Survival Rate | 3 | 2021 | 12773 | 0.090 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6891 | 0.090 |
Why?
|
Reference Standards | 1 | 2014 | 1020 | 0.090 |
Why?
|
Exercise | 2 | 2021 | 5611 | 0.090 |
Why?
|
Lipolysis | 1 | 2011 | 211 | 0.090 |
Why?
|
Telemetry | 1 | 2011 | 205 | 0.090 |
Why?
|
Fistula | 1 | 2012 | 218 | 0.090 |
Why?
|
Minority Groups | 1 | 2018 | 1215 | 0.090 |
Why?
|
Shock | 1 | 2012 | 318 | 0.090 |
Why?
|
Tea | 1 | 2011 | 275 | 0.090 |
Why?
|
Tonometry, Ocular | 1 | 2011 | 237 | 0.090 |
Why?
|
Kidney | 2 | 2018 | 7167 | 0.090 |
Why?
|
Hepatic Encephalopathy | 1 | 2011 | 139 | 0.090 |
Why?
|
Television | 1 | 2013 | 409 | 0.090 |
Why?
|
Malaria | 1 | 2020 | 1232 | 0.090 |
Why?
|
Mitochondria, Muscle | 1 | 2011 | 171 | 0.090 |
Why?
|
Intraoperative Period | 1 | 2011 | 520 | 0.090 |
Why?
|
Bone Marrow Transplantation | 1 | 2018 | 2763 | 0.090 |
Why?
|
Colectomy | 1 | 2015 | 681 | 0.090 |
Why?
|
Lipids | 2 | 2011 | 3302 | 0.090 |
Why?
|
Abdomen | 1 | 2016 | 1107 | 0.090 |
Why?
|
Fruit | 1 | 2015 | 1139 | 0.090 |
Why?
|
Methylation | 1 | 2012 | 1107 | 0.090 |
Why?
|
Cation Transport Proteins | 1 | 2012 | 327 | 0.090 |
Why?
|
Lung Injury | 1 | 2014 | 436 | 0.080 |
Why?
|
Chemokine CCL2 | 1 | 2011 | 617 | 0.080 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2011 | 358 | 0.080 |
Why?
|
Ischemia | 1 | 2018 | 1911 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39004 | 0.080 |
Why?
|
Developing Countries | 1 | 2021 | 2789 | 0.080 |
Why?
|
Warfarin | 1 | 2017 | 1493 | 0.080 |
Why?
|
Lens, Crystalline | 1 | 2011 | 388 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13655 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2018 | 4379 | 0.080 |
Why?
|
Cell Hypoxia | 1 | 2011 | 675 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2130 | 0.080 |
Why?
|
Appendicitis | 1 | 2015 | 644 | 0.080 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2011 | 257 | 0.080 |
Why?
|
Substrate Specificity | 1 | 2012 | 1802 | 0.080 |
Why?
|
PPAR gamma | 1 | 2011 | 493 | 0.080 |
Why?
|
Linear Models | 3 | 2014 | 5948 | 0.080 |
Why?
|
Host-Pathogen Interactions | 1 | 2017 | 1477 | 0.080 |
Why?
|
Adenovirus Infections, Human | 1 | 2008 | 71 | 0.080 |
Why?
|
Resuscitation | 1 | 2012 | 657 | 0.080 |
Why?
|
Light | 1 | 2014 | 1374 | 0.080 |
Why?
|
Sequence Alignment | 1 | 2012 | 2257 | 0.080 |
Why?
|
Leptin | 2 | 2016 | 1593 | 0.080 |
Why?
|
Indiana | 2 | 2018 | 92 | 0.080 |
Why?
|
Lactic Acid | 1 | 2013 | 1132 | 0.080 |
Why?
|
Helicobacter pylori | 1 | 2011 | 381 | 0.080 |
Why?
|
Energy Metabolism | 1 | 2019 | 2896 | 0.080 |
Why?
|
Helicobacter Infections | 1 | 2011 | 385 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10943 | 0.080 |
Why?
|
Troponin T | 1 | 2012 | 749 | 0.080 |
Why?
|
Selection, Genetic | 1 | 2012 | 914 | 0.080 |
Why?
|
Hypolipidemic Agents | 1 | 2012 | 604 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2014 | 1780 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 627 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1175 | 0.070 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1813 | 0.070 |
Why?
|
Myocardial Infarction | 3 | 2020 | 11690 | 0.070 |
Why?
|
Asymptomatic Diseases | 2 | 2020 | 552 | 0.070 |
Why?
|
Child, Preschool | 7 | 2018 | 40955 | 0.070 |
Why?
|
Child | 8 | 2018 | 77478 | 0.070 |
Why?
|
Comorbidity | 2 | 2011 | 10372 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1967 | 0.070 |
Why?
|
HIV Infections | 1 | 2012 | 16678 | 0.070 |
Why?
|
General Surgery | 1 | 2017 | 1633 | 0.070 |
Why?
|
Pilot Projects | 1 | 2019 | 8297 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2011 | 4933 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3847 | 0.070 |
Why?
|
Cholesterol | 2 | 2015 | 2895 | 0.070 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3040 | 0.070 |
Why?
|
Luminescence | 2 | 2016 | 137 | 0.060 |
Why?
|
Double-Blind Method | 6 | 2018 | 12017 | 0.060 |
Why?
|
Postoperative Complications | 6 | 2023 | 15244 | 0.060 |
Why?
|
Intraocular Pressure | 1 | 2011 | 1274 | 0.060 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 2951 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4751 | 0.060 |
Why?
|
Reoperation | 2 | 2013 | 4200 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2195 | 0.060 |
Why?
|
Overweight | 2 | 2013 | 2366 | 0.060 |
Why?
|
Explosions | 2 | 2015 | 109 | 0.060 |
Why?
|
Chromosome Mapping | 1 | 2013 | 4742 | 0.060 |
Why?
|
Adipocytes | 1 | 2011 | 1182 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2016 | 4414 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2013 | 12242 | 0.060 |
Why?
|
Adenoviridae | 1 | 2008 | 1096 | 0.060 |
Why?
|
Biological Assay | 1 | 2007 | 652 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 2011 | 1188 | 0.060 |
Why?
|
Reference Values | 1 | 2011 | 4982 | 0.060 |
Why?
|
Social Class | 1 | 2012 | 1995 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2012 | 1195 | 0.060 |
Why?
|
Ultrasonography | 2 | 2016 | 5978 | 0.060 |
Why?
|
Fatty Liver | 1 | 2009 | 728 | 0.060 |
Why?
|
Fatty Acids | 1 | 2011 | 1806 | 0.060 |
Why?
|
Proteome | 1 | 2013 | 1790 | 0.060 |
Why?
|
Seeds | 2 | 2014 | 105 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1331 | 0.060 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1914 | 0.060 |
Why?
|
Animals | 8 | 2014 | 168561 | 0.050 |
Why?
|
Age Distribution | 2 | 2020 | 2900 | 0.050 |
Why?
|
Mitochondria | 1 | 2016 | 3520 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 18112 | 0.050 |
Why?
|
Surgical Flaps | 1 | 2011 | 1634 | 0.050 |
Why?
|
Risk Assessment | 4 | 2023 | 23320 | 0.050 |
Why?
|
Glucose | 2 | 2011 | 4391 | 0.050 |
Why?
|
Registries | 2 | 2018 | 8077 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4681 | 0.050 |
Why?
|
Hyperglycemia | 1 | 2010 | 1368 | 0.050 |
Why?
|
Suicide | 1 | 2012 | 1475 | 0.050 |
Why?
|
Stroke | 3 | 2020 | 9963 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2011 | 1864 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2012 | 2145 | 0.050 |
Why?
|
Health Care Costs | 1 | 2014 | 3203 | 0.050 |
Why?
|
Poverty | 1 | 2012 | 2646 | 0.050 |
Why?
|
United States | 6 | 2023 | 69693 | 0.050 |
Why?
|
Cohort Studies | 5 | 2017 | 40450 | 0.050 |
Why?
|
Respiration, Artificial | 1 | 2011 | 2566 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 13814 | 0.050 |
Why?
|
Insulin | 2 | 2015 | 6575 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2007 | 1350 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2018 | 5724 | 0.040 |
Why?
|
Anaerobiosis | 1 | 2019 | 140 | 0.040 |
Why?
|
Life Style | 1 | 2011 | 3824 | 0.040 |
Why?
|
Rats | 2 | 2014 | 24265 | 0.040 |
Why?
|
Collagen Type V | 1 | 2018 | 16 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2014 | 18006 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2019 | 354 | 0.040 |
Why?
|
Intra-Abdominal Fat | 2 | 2014 | 591 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10232 | 0.040 |
Why?
|
Diet | 1 | 2016 | 7923 | 0.040 |
Why?
|
Phlebography | 1 | 2019 | 333 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 13029 | 0.040 |
Why?
|
Primary Health Care | 2 | 2014 | 4551 | 0.040 |
Why?
|
Research Design | 2 | 2014 | 5979 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11472 | 0.040 |
Why?
|
Stress, Psychological | 1 | 2012 | 4229 | 0.040 |
Why?
|
Boston | 3 | 2015 | 9305 | 0.040 |
Why?
|
Internship and Residency | 1 | 2017 | 5774 | 0.040 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2749 | 0.040 |
Why?
|
Drug Therapy, Combination | 3 | 2013 | 6483 | 0.040 |
Why?
|
Narcotic Antagonists | 2 | 2013 | 562 | 0.040 |
Why?
|
Elastin | 1 | 2018 | 305 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2018 | 258 | 0.040 |
Why?
|
Tissue Culture Techniques | 2 | 2008 | 291 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20086 | 0.030 |
Why?
|
Fluid Shifts | 1 | 2016 | 19 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2018 | 520 | 0.030 |
Why?
|
Abdominal Wound Closure Techniques | 1 | 2016 | 33 | 0.030 |
Why?
|
Prospective Studies | 3 | 2020 | 53187 | 0.030 |
Why?
|
Vascular Patency | 1 | 2018 | 885 | 0.030 |
Why?
|
Fluoroscopy | 1 | 2020 | 924 | 0.030 |
Why?
|
Varicose Veins | 1 | 2017 | 154 | 0.030 |
Why?
|
Hypertrophy | 1 | 2017 | 568 | 0.030 |
Why?
|
Lung | 1 | 2014 | 9826 | 0.030 |
Why?
|
Limb Salvage | 1 | 2018 | 433 | 0.030 |
Why?
|
Seed Storage Proteins | 1 | 2014 | 12 | 0.030 |
Why?
|
Plant Shoots | 1 | 2014 | 25 | 0.030 |
Why?
|
Louisiana | 1 | 2014 | 109 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2018 | 1013 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6534 | 0.030 |
Why?
|
Peritoneal Lavage | 1 | 2014 | 35 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2016 | 792 | 0.030 |
Why?
|
Seasons | 1 | 2020 | 1492 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6294 | 0.030 |
Why?
|
Fasting | 2 | 2011 | 1589 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2018 | 656 | 0.030 |
Why?
|
Holidays | 1 | 2013 | 42 | 0.030 |
Why?
|
Anthocyanins | 1 | 2013 | 76 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1916 | 0.030 |
Why?
|
Hernia, Diaphragmatic | 1 | 2014 | 250 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2012 | 6454 | 0.030 |
Why?
|
Rupture | 1 | 2014 | 430 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2013 | 211 | 0.030 |
Why?
|
Sexual Behavior, Animal | 1 | 2013 | 113 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2295 | 0.030 |
Why?
|
Biosynthetic Pathways | 1 | 2013 | 137 | 0.030 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2016 | 1155 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1200 | 0.030 |
Why?
|
Balloon Occlusion | 1 | 2013 | 126 | 0.030 |
Why?
|
Thoracostomy | 1 | 2012 | 72 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2018 | 2557 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2014 | 766 | 0.030 |
Why?
|
Tinidazole | 1 | 2011 | 2 | 0.030 |
Why?
|
Hematuria | 1 | 2013 | 235 | 0.030 |
Why?
|
Motor Activity | 2 | 2013 | 2714 | 0.030 |
Why?
|
Leisure Activities | 1 | 2013 | 311 | 0.020 |
Why?
|
Hyperemia | 1 | 2012 | 224 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15056 | 0.020 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2011 | 35 | 0.020 |
Why?
|
Diastole | 1 | 2013 | 791 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2011 | 197 | 0.020 |
Why?
|
Glasgow Coma Scale | 1 | 2013 | 570 | 0.020 |
Why?
|
Puerto Rico | 1 | 2012 | 356 | 0.020 |
Why?
|
Clarithromycin | 1 | 2011 | 86 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3510 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2011 | 159 | 0.020 |
Why?
|
Rib Fractures | 1 | 2012 | 131 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1661 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1768 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1095 | 0.020 |
Why?
|
Educational Measurement | 1 | 2017 | 1206 | 0.020 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2013 | 503 | 0.020 |
Why?
|
Ammonia | 1 | 2011 | 239 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 21719 | 0.020 |
Why?
|
Ceramides | 1 | 2011 | 198 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 35342 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2013 | 965 | 0.020 |
Why?
|
Chemokines | 1 | 2014 | 954 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 677 | 0.020 |
Why?
|
Random Allocation | 1 | 2014 | 2425 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2018 | 19223 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5062 | 0.020 |
Why?
|
Upper Extremity | 1 | 2013 | 648 | 0.020 |
Why?
|
Animal Feed | 1 | 2008 | 110 | 0.020 |
Why?
|
Adipogenesis | 1 | 2011 | 358 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4211 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9144 | 0.020 |
Why?
|
Accidents, Traffic | 1 | 2014 | 819 | 0.020 |
Why?
|
Doxazosin | 1 | 2008 | 19 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2924 | 0.020 |
Why?
|
Anilides | 1 | 2011 | 404 | 0.020 |
Why?
|
Ghrelin | 1 | 2010 | 266 | 0.020 |
Why?
|
Mice, Obese | 1 | 2008 | 424 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15530 | 0.020 |
Why?
|
Device Removal | 1 | 2013 | 652 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3738 | 0.020 |
Why?
|
Angiogenesis Modulating Agents | 1 | 2007 | 8 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1265 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 20928 | 0.020 |
Why?
|
Cost of Illness | 1 | 2017 | 1852 | 0.020 |
Why?
|
Oxygen | 1 | 2019 | 4169 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1164 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3862 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5519 | 0.020 |
Why?
|
Lipectomy | 1 | 2008 | 118 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2013 | 786 | 0.020 |
Why?
|
Canada | 1 | 2012 | 2061 | 0.020 |
Why?
|
Qualitative Research | 1 | 2015 | 2680 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2012 | 1599 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2018 | 1794 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2013 | 657 | 0.020 |
Why?
|
Lower Extremity | 1 | 2013 | 1151 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2187 | 0.020 |
Why?
|
Hemorrhage | 1 | 2017 | 3461 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6365 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2283 | 0.020 |
Why?
|
Critical Illness | 1 | 2018 | 2665 | 0.020 |
Why?
|
Thrombin | 1 | 2007 | 598 | 0.020 |
Why?
|
Receptor, Insulin | 1 | 2008 | 846 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2018 | 5310 | 0.010 |
Why?
|
Fibrinogen | 1 | 2007 | 894 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5655 | 0.010 |
Why?
|
Exercise Test | 1 | 2011 | 2075 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2014 | 8300 | 0.010 |
Why?
|
Patient Readmission | 1 | 2017 | 3111 | 0.010 |
Why?
|
Laparoscopy | 1 | 2015 | 2121 | 0.010 |
Why?
|
ras Proteins | 1 | 2008 | 1060 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2012 | 2049 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 2956 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12958 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4801 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 7010 | 0.010 |
Why?
|
Psychometrics | 1 | 2011 | 2999 | 0.010 |
Why?
|
Neutrophils | 1 | 2014 | 3711 | 0.010 |
Why?
|
Communication | 1 | 2015 | 3728 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9846 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10163 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8662 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2012 | 3294 | 0.010 |
Why?
|
Proteomics | 1 | 2013 | 3618 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2013 | 3679 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2012 | 2536 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2938 | 0.010 |
Why?
|
Placenta | 1 | 2007 | 1694 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12344 | 0.010 |
Why?
|
Coronary Disease | 1 | 2012 | 6078 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2008 | 3164 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2008 | 2838 | 0.010 |
Why?
|
Mice | 2 | 2011 | 81045 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9581 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2007 | 19862 | 0.010 |
Why?
|
Heart Failure | 1 | 2012 | 10856 | 0.000 |
Why?
|